181 related articles for article (PubMed ID: 22033273)
21. High circulating insulin-like growth factor-1 reduces the risk of renal cell carcinoma: a Mendelian randomization study.
Chen M; Tsai CW; Chang WS; Xiong GY; Xu Y; Bau DT; Gu J
Carcinogenesis; 2021 Jun; 42(6):826-830. PubMed ID: 33852723
[TBL] [Abstract][Full Text] [Related]
22. Augmented telomerase activity, reduced telomere length and the presence of alternative lengthening of telomere in renal cell carcinoma: plausible predictive and diagnostic markers.
Pal D; Sharma U; Khajuria R; Singh SK; Kakkar N; Prasad R
Gene; 2015 May; 562(2):145-51. PubMed ID: 25769384
[TBL] [Abstract][Full Text] [Related]
23. Telomere length in peripheral blood leukocytes and risk of renal cell carcinoma.
Park JY; Luu HN; Park HY; Lin HY; Radlein S; Di Pietro G; Yeo CD; Kim SJ; Kang N; Antwi S; Sexton WJ; Spiess PE; Dickinson S; Parker A
Transl Cancer Res; 2019 Jul; 8(Suppl 4):S397-S403. PubMed ID: 35117117
[TBL] [Abstract][Full Text] [Related]
24. Cord blood telomere length in Latino infants: relation with maternal education and infant sex.
Wojcicki JM; Olveda R; Heyman MB; Elwan D; Lin J; Blackburn E; Epel E
J Perinatol; 2016 Mar; 36(3):235-41. PubMed ID: 26633142
[TBL] [Abstract][Full Text] [Related]
25. A case-control study of occupation/industry and renal cell carcinoma risk.
Karami S; Colt JS; Schwartz K; Davis FG; Ruterbusch JJ; Munuo SS; Wacholder S; Stewart PA; Graubard BI; Rothman N; Chow WH; Purdue MP
BMC Cancer; 2012 Aug; 12():344. PubMed ID: 22873580
[TBL] [Abstract][Full Text] [Related]
26. Association of longer telomere length in cancer cells and cancer-associated fibroblasts with worse prognosis.
Matsuda Y; Ye J; Yamakawa K; Mukai Y; Azuma K; Wu L; Masutomi K; Yamashita T; Daigo Y; Miyagi Y; Yokose T; Oshima T; Ito H; Morinaga S; Kishida T; Minamoto T; Kojima M; Kaneko S; Haba R; Kontani K; Kanaji N; Okano K; Muto-Ishizuka M; Yokohira M; Saoo K; Imaida K; Suizu F
J Natl Cancer Inst; 2023 Feb; 115(2):208-218. PubMed ID: 36567450
[TBL] [Abstract][Full Text] [Related]
27. Genetic variants in a long noncoding RNA related to Sunitinib Resistance predict risk and survival of patients with renal cell carcinoma.
Xing Q; Li R; Xu A; Qin Z; Tang J; Zhang L; Tang M; Han P; Wang W; Qin C; Du M; Zhang W
Cancer Med; 2019 Jun; 8(6):2886-2896. PubMed ID: 31038847
[TBL] [Abstract][Full Text] [Related]
28. The individual blood cell telomere attrition rate is telomere length dependent.
Nordfjäll K; Svenson U; Norrback KF; Adolfsson R; Lenner P; Roos G
PLoS Genet; 2009 Feb; 5(2):e1000375. PubMed ID: 19214207
[TBL] [Abstract][Full Text] [Related]
29. Association of decreased mean platelet volume with renal cell carcinoma.
Yun ZY; Zhang X; Liu ZP; Liu T; Wang RT; Chen H
Int J Clin Oncol; 2017 Dec; 22(6):1076-1080. PubMed ID: 28664301
[TBL] [Abstract][Full Text] [Related]
30. Risk of renal cell carcinoma and polymorphism in phase I xenobiotic metabolizing CYP1A1 and CYP2D6 enzymes.
Ahmad ST; Arjumand W; Seth A; Nafees S; Rashid S; Ali N; Hamiza OO; Sultana S
Urol Oncol; 2013 Oct; 31(7):1350-7. PubMed ID: 22281432
[TBL] [Abstract][Full Text] [Related]
31. LINE-1 methylation levels in leukocyte DNA and risk of renal cell cancer.
Liao LM; Brennan P; van Bemmel DM; Zaridze D; Matveev V; Janout V; Kollarova H; Bencko V; Navratilova M; Szeszenia-Dabrowska N; Mates D; Rothman N; Boffetta P; Chow WH; Moore LE
PLoS One; 2011; 6(11):e27361. PubMed ID: 22076155
[TBL] [Abstract][Full Text] [Related]
32. Shorter telomere length is associated with increased ovarian cancer risk in both familial and sporadic cases.
Martinez-Delgado B; Yanowsky K; Inglada-Perez L; de la Hoya M; Caldes T; Vega A; Blanco A; Martin T; Gonzalez-Sarmiento R; Blasco M; Robledo M; Urioste M; Song H; Pharoah P; Benitez J
J Med Genet; 2012 May; 49(5):341-4. PubMed ID: 22493152
[TBL] [Abstract][Full Text] [Related]
33. Expression Levels of PIWI-interacting RNA, piR-823, Are Deregulated in Tumor Tissue, Blood Serum and Urine of Patients with Renal Cell Carcinoma.
Iliev R; Fedorko M; Machackova T; Mlcochova H; Svoboda M; Pacik D; Dolezel J; Stanik M; Slaby O
Anticancer Res; 2016 Dec; 36(12):6419-6423. PubMed ID: 27919963
[TBL] [Abstract][Full Text] [Related]
34. Hypertension, antihypertensives and mutations in the Von Hippel-Lindau gene in renal cell carcinoma: results from the Netherlands Cohort Study.
Schouten LJ; van Dijk BA; Oosterwijk E; Hulsbergen-van de Kaa CA; Kiemeney LA; Goldbohm RA; Schalken JA; van den Brandt PA
J Hypertens; 2005 Nov; 23(11):1997-2004. PubMed ID: 16208141
[TBL] [Abstract][Full Text] [Related]
35. A Prospective Study of Leukocyte Telomere Length and Risk of Gestational Diabetes in a Multiracial Cohort.
Lin Y; Zhu Y; Wu J; Hinkle SN; Rawal S; Han J; Weir NL; Tsai MY; Zhang C
Epidemiology; 2019 Nov; 30 Suppl 2(Suppl 2):S10-S16. PubMed ID: 31569148
[TBL] [Abstract][Full Text] [Related]
36. Family history and risk of renal cell carcinoma: results from a case-control study and systematic meta-analysis.
Clague J; Lin J; Cassidy A; Matin S; Tannir NM; Tamboli P; Wood CG; Wu X
Cancer Epidemiol Biomarkers Prev; 2009 Mar; 18(3):801-7. PubMed ID: 19240244
[TBL] [Abstract][Full Text] [Related]
37. Physical activity and renal cell carcinoma among black and white Americans: a case-control study.
Xiao Q; Liao L; Matthews CE; Chow WH; Davis F; Schwartz K; Purdue M; Hofmann JN; Colt J
BMC Cancer; 2014 Sep; 14():707. PubMed ID: 25253394
[TBL] [Abstract][Full Text] [Related]
38. Glutathione S-transferase M1, T1, and P1 polymorphisms as risk factors for renal cell carcinoma: a case-control study.
Sweeney C; Farrow DC; Schwartz SM; Eaton DL; Checkoway H; Vaughan TL
Cancer Epidemiol Biomarkers Prev; 2000 Apr; 9(4):449-54. PubMed ID: 10794492
[TBL] [Abstract][Full Text] [Related]
39. Family history and risk of renal cell carcinoma.
Gago-Dominguez M; Yuan JM; Castelao JE; Ross RK; Yu MC
Cancer Epidemiol Biomarkers Prev; 2001 Sep; 10(9):1001-4. PubMed ID: 11535554
[TBL] [Abstract][Full Text] [Related]
40. Vitamin D receptor gene polymorphisms are associated with increased risk and progression of renal cell carcinoma in a Japanese population.
Obara W; Suzuki Y; Kato K; Tanji S; Konda R; Fujioka T
Int J Urol; 2007 Jun; 14(6):483-7. PubMed ID: 17593089
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
